A step closer to autologous cell therapy for Parkinson's disease
- PMID: 33798419
- DOI: 10.1016/j.stem.2021.03.010
A step closer to autologous cell therapy for Parkinson's disease
Abstract
In a recent report in Nature Medicine, Tao et al. (2021) demonstrate that MPTP-treated monkeys receiving autologous, but not allogeneic, transplantation showed significant long-term improvement in motor and depressive behaviors, supporting the feasibility of autologous cell therapy for Parkinson's disease (PD).
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests K.S.K. is a co-inventor of the US patent 9,657,273 and co-inventor of the US patent applications US 15/036,235 and US 16/483,107, which are owned by McLean Hospital.
Comment on
-
Autologous transplant therapy alleviates motor and depressive behaviors in parkinsonian monkeys.Nat Med. 2021 Apr;27(4):632-639. doi: 10.1038/s41591-021-01257-1. Epub 2021 Mar 1. Nat Med. 2021. PMID: 33649496 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources